Adrienne G. Waks
Clinical trials sponsored by Adrienne G. Waks, explained in plain language.
-
Could immune activators revive treatment for Hard-to-Treat breast cancer?
Disease control OngoingThis phase 2 trial tests whether adding immune-boosting drugs (avelumab and utomilumab) to standard chemotherapy and targeted therapy can help people with HER2-positive metastatic breast cancer whose disease has worsened after prior treatments. Participants are randomly assigned …
Phase: PHASE2 • Sponsor: Adrienne G. Waks • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New drug duo aims to tackle Hard-to-Treat breast cancer
Disease control OngoingThis phase 2 trial tests the safety and effectiveness of combining sacituzumab govitecan (Trodelvy) with trastuzumab (Herceptin) in 28 people with HER2+ metastatic breast cancer that has worsened after treatment with trastuzumab deruxtecan. The goal is to see how many participant…
Phase: PHASE2 • Sponsor: Adrienne G. Waks • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC